Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 - Hecht, M; Gostian, AO; Eckstein, M (J Immunother Cancer, 2020)